What's the problem? [Regulatives / Guidelines]
Hi all,
Recently we did pilot and pivotal (Partial reference replicate) studies for WHO and we got high variability (CV=32%). In the USFDA product specific guidance they have suggested 2x2 crossover design for this drug. Based on our prior experience can we perform reference replicate study or need to go as per guidance?
Recently we did pilot and pivotal (Partial reference replicate) studies for WHO and we got high variability (CV=32%). In the USFDA product specific guidance they have suggested 2x2 crossover design for this drug. Based on our prior experience can we perform reference replicate study or need to go as per guidance?

—
Kumar Naidu
Kumar Naidu
Complete thread:
- Highly Variable Drug BE Justification jag009 2017-03-20 04:42 [Regulatives / Guidelines]
- Highly Variable Drug BE Justification ElMaestro 2017-03-20 06:55
- Study costs: Replicate vs. 2×2×2 Helmut 2017-03-20 13:12
- Study costs: Replicate seems to be cheaper VStus 2017-03-21 12:49
- Study costs: Replicate seems to be cheaper Dr_Dan 2017-03-21 13:06
- Study costs: Replicate seems to be cheaper Helmut 2017-03-21 14:50
- expected power d_labes 2017-03-21 15:16
- Doesn't hurt! VStus 2017-03-23 14:24
- Study costs: Replicate seems to be cheaper Helmut 2017-03-21 14:50
- Study costs: Replicate seems to be cheaper Dr_Dan 2017-03-21 13:06
- Study costs: Replicate vs. 2×2×2 mahmoud-teaima 2017-03-23 08:17
- Study costs: Replicate vs. 2×2×2 M.tareq 2017-05-07 21:21
- Replicate vs. 2×2×2 (ethics?) Helmut 2017-05-08 14:21
- Replicate vs. 2×2×2 (ethics?) nobody 2017-05-08 14:52
- Applicability of reference-scaling Helmut 2017-05-10 14:10
- Replicate vs. 2×2×2 M.tareq 2017-05-14 23:04
- Replicate vs. 2×2×2 Helmut 2017-05-15 19:07
- Replicate vs. 2×2×2 M.tareq 2017-05-15 21:02
- Regulators view of HVD drugs DavidManteigas 2017-05-16 12:41
- Regulators view of HVD drugs Helmut 2017-05-16 15:01
- What's the problem? ElMaestro 2017-05-17 03:30
- What's the problem? nobody 2017-05-17 07:48
- What's the problem? nobody 2017-05-17 09:31
- What's the problem? DavidManteigas 2017-05-17 11:25
- What's the problem? ElMaestro 2017-05-17 12:07
- What's the problem?kumarnaidu 2017-07-11 14:43
- What's the problem? ElMaestro 2017-07-11 14:56
- What's the problem?kumarnaidu 2017-07-11 14:43
- What's the problem? ElMaestro 2017-05-17 12:07
- What's the problem? DavidManteigas 2017-05-17 11:25
- What's the problem? nobody 2017-05-17 09:31
- What's the problem? nobody 2017-05-17 07:48
- Replicate vs. 2×2×2 Helmut 2017-05-15 19:07
- Replicate vs. 2×2×2 (ethics?) nobody 2017-05-08 14:52
- Replicate vs. 2×2×2 (ethics?) Helmut 2017-05-08 14:21
- Study costs: Replicate seems to be cheaper VStus 2017-03-21 12:49
- Study costs: Replicate vs. 2×2×2 Helmut 2017-03-20 13:12
- Highly Variable Drug BE Justification ElMaestro 2017-03-20 06:55